Literature DB >> 17103175

Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes.

Tomohiro Tanikawa1, Yuko Waguri-Nagaya, Takuma Kusabe, Mineyoshi Aoyama, Kiyofumi Asai, Takanobu Otsuka.   

Abstract

Gliostatin/thymidine phosphorylase (GLS/TP) is known to have angiogenic and arthritogenic activities. The purpose of this study was to elucidate whether GLS/TP is involved in the regulation of the angiogenic cytokine vascular endothelial growth factor (VEGF) in rheumatoid arthritis (RA). Fibroblast-like synoviocytes (FLSs) from patients with RA were cultured and stimulated with recombinant human GLS (rHuGLS) and interleukin (IL)-1beta. Immunohistochemistry showed that GLS/TP and VEGF were detectable in the synovial lining cells. In cultured FLSs, both VEGF mRNA and protein levels were markedly increased by rHuIL-1beta treatment. rHuGLS increased VEGF mRNA expression in a dose-dependent manner. We detected high concentrations of VEGF165 protein in culture supernatants from FLSs treated with rHuGLS (300 ng/ml), which were comparable to GLS levels found in synovial fluid of RA patients. These findings indicate that GLS/TP and VEGF have synergistic effects on angiogenesis in rheumatoid synovitis, and that GLS/TP has a role in regulating VEGF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103175     DOI: 10.1007/s00296-006-0258-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis.

Authors:  S Hirohata; J Sakakibara
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

2.  Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

Authors:  B Berse; J A Hunt; R J Diegel; P Morganelli; K Yeo; F Brown; R A Fava
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer.

Authors:  N Seki; J Kodama; A Hongo; Y Miyagi; M Yoshinouchi; T Kudo
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

4.  Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.

Authors:  H Muro; Y Waguri-Nagaya; Y Mukofujiwara; T Iwahashi; T Otsuka; N Matsui; A Moriyama; K Asai; T Kato
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

5.  A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma.

Authors:  K Asai; T Hirano; S Kaneko; A Moriyama; K Nakanishi; I Isobe; Y Z Eksioglu; T Kato
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

6.  High concentrations of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis.

Authors:  K Asai; T Hirano; K Matsukawa; J Kusada; M Takeuchi; T Otsuka; N Matsui; T Kato
Journal:  Clin Chim Acta       Date:  1993-09-17       Impact factor: 3.786

7.  Neurotrophic action of gliostatin on cortical neurons. Identity of gliostatin and platelet-derived endothelial cell growth factor.

Authors:  K Asai; K Nakanishi; I Isobe; Y Z Eksioglu; A Hirano; K Hama; T Miyamoto; T Kato
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

8.  Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase.

Authors:  K Miyadera; T Sumizawa; M Haraguchi; H Yoshida; W Konstanty; Y Yamada; S Akiyama
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

9.  Thymidine phosphorylase is angiogenic and promotes tumor growth.

Authors:  A Moghaddam; H T Zhang; T P Fan; D E Hu; V C Lees; H Turley; S B Fox; K C Gatter; A L Harris; R Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Authors:  R A Fava; N J Olsen; G Spencer-Green; K T Yeo; T K Yeo; B Berse; R W Jackman; D R Senger; H F Dvorak; L F Brown
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  4 in total

1.  FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes.

Authors:  Takaya Yamagami; Yuko Waguri-Nagaya; Kenji Ikuta; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Rheumatol Int       Date:  2010-03-18       Impact factor: 2.631

2.  The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes.

Authors:  Kenji Ikuta; Yuko Waguri-Nagaya; Kae Kikuchi; Takaya Yamagami; Masahiro Nozaki; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Arthritis Res Ther       Date:  2012-04-25       Impact factor: 5.156

Review 3.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

4.  The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.

Authors:  Yuji Joyo; Yohei Kawaguchi; Hiroki Yonezu; Hiroya Senda; Sanshiro Yasuma; Hiroo Shiraga; Masahiro Nozaki; Mineyoshi Aoyama; Kiyofumi Asai; Hideki Murakami; Yuko Waguri-Nagaya
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.